Eculizumab for treating atypical haemolytic uraemic syndrome

Committee papers (PDF 512 KB)

Eculizumab for treating atypical haemolytic uraemic syndrome: Equality impact assessment - guidance development (PDF 168 KB)

Atypical haemolytic uraemic syndrome (aHUS) - eculizumab: final evaluation determination information

Atypical haemolytic uraemic syndrome (aHUS) - eculizumab: final evaluation document (PDF 177 KB)

Atypical haemolytic uraemic syndrome (aHUS) - eculizumab: evaluation consultation 2

Atypical haemolytic uraemic syndrome (aHUS) - eculizumab: evaluation consultation document 2 information

Atypical haemolytic uraemic syndrome (aHUS) - eculizumab: evaluation report 2 information

Atypical haemolytic uraemic syndrome (aHUS) - eculizumab: evaluation report 2 (PDF 3.16 MB)

Atypical haemolytic uraemic syndrome (aHUS) - eculizumab: evaluation consultation

Atypical haemolytic uraemic syndrome (aHUS) - eculizumab: evaluation consultation document information

Atypical haemolytic uraemic syndrome (aHUS) - eculizumab: evaluation report information

Atypical haemolytic uraemic syndrome (aHUS) - eculizumab: evaluation report (PDF 6.03 MB)

Atypical haemolytic uraemic syndrome (aHUS) ? eculizumab: final scope (PDF 96 KB)

Atypical haemolytic uraemic syndrome (aHUS) ? eculizumab: final matrix (PDF 101 KB)

Atypical haemolytic uraemic syndrome (aHUS) - eculizumab - response to consultee and commentator comments on the draft scope (PDF 94 KB)